Metlife Given Consensus Rating of “Buy” by Analysts (NYSE:MET)
Metlife (NYSE:MET) has received an average rating of “Buy” from the twenty-one ratings firms that are currently covering the stock, American Banking and Market News reports. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $57.80.
MET has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Metlife in a research note on Tuesday. They now have a $63.00 price target on the stock, up previously from $58.00. Separately, analysts at S&P Equity Research reiterated a “buy” rating on shares of Metlife in a research note on Wednesday, June 11th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Metlife in a research note on Wednesday, June 11th. They now have a $57.00 price target on the stock.
Metlife (NYSE:MET) opened at 56.18 on Wednesday. Metlife has a 1-year low of $45.52 and a 1-year high of $56.87. The stock’s 50-day moving average is $53.45 and its 200-day moving average is $52.14. The company has a market cap of $63.235 billion and a P/E ratio of 17.61.
Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $1.37 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.40 by $0.03. Analysts expect that Metlife will post $5.66 EPS for the current fiscal year.
MetLife, Inc (NYSE:MET) is a provider of insurance, annuities and employee benefit programs, serving 90 million customers in over 50 countries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.